Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 12, 2022

Total Value ($000): $369,138 (100.0% shares, 0.0% debt)

Holdings (7)

CNTA CENTESSA PHARMACEUTICALS PLC 48.5%

Value ($000) $179,070 Shares 19,963,157 Est. Cost $20.88 Unrealized —

AURA AURA BIOSCIENCES INC 18.1%

Value ($000) $66,878 Shares 3,039,892 Est. Cost $17.87 Unrealized +6.6%

PCVX VAXCYTE INC 12.3%

Value ($000) $45,582 Shares 1,887,478 Est. Cost $32.16 Unrealized -32.1%

— MERUS N V 11.5%

Value ($000) $42,304 Shares 1,600,000 Est. Cost $14.08 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 7.6%

Value ($000) $28,143 Shares 2,067,861 Est. Cost $25.13 Unrealized -35.7%

— CHECKMATE PHARMACEUTICALS IN 1.3%

Value ($000) $4,790 Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 0.6%

Value ($000) $2,371 Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$179,070	48.5%	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$66,878	18.1%	$17.87	+6.6%	COM	05153U107
PCVX	VAXCYTE INC	1,887,478	$45,582	12.3%	$32.16	-32.1%	COM	92243G108
—	MERUS N V	1,600,000	$42,304	11.5%	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$28,143	7.6%	$25.13	-35.7%	COM	71722W107
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$4,790	1.3%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$2,371	0.6%	$3.82	—	COM	H5861P103